Daiwa Securities Group Inc. Intellia Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 2,852 shares of NTLA stock, worth $34,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,852

Previous 2,883 1.08%

Holding current value

$34,737

Previous $65,000 9.23%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$19.72 - $27.36 $611 - $848	-31 Reduced 1.08%	2,852 $59,000
Q2 2024 Aug 07, 2024	SELL	$20.02 - $27.22 $100 - $136	-5 Reduced 0.17%	2,883 $65,000
Q1 2024 May 02, 2024	SELL	$23.82 - $32.8 $4,001 - $5,510	-168 Reduced 5.5%	2,888 $79,000
Q4 2023 Jan 31, 2024	BUY	$23.16 - $32.34 $18,365 - $25,645	793 Added 35.04%	3,056 $93,000
Q2 2023 Jul 31, 2023	BUY	$34.58 - $46.03 $2,213 - $2,945	64 Added 2.91%	2,263 $92,000
Q1 2023 May 02, 2023	BUY	$33.3 - $44.82 $12,320 - $16,583	370 Added 20.23%	2,199 $82,000
Q4 2022 Feb 06, 2023	BUY	$33.21 - $62.69 $3,387 - $6,394	102 Added 5.91%	1,829 $64,000
Q3 2022 Nov 02, 2022	SELL	$53.92 - $71.7 $24,102 - $32,049	-447 Reduced 20.56%	1,727 $97,000
Q2 2022 Aug 09, 2022	BUY	$38.49 - $76.21 $75,324 - $149,142	1,957 Added 901.84%	2,174 $113,000
Q4 2021 Feb 03, 2022	SELL	$100.76 - $138.36 $3,526 - $4,842	-35 Reduced 13.89%	217 $26,000
Q3 2021 Nov 05, 2021	BUY	$132.37 - $176.78 $15,619 - $20,860	118 Added 88.06%	252 $34,000
Q1 2021 May 03, 2021	BUY	$46.59 - $83.68 $1,071 - $1,924	23 Added 20.72%	134 $11,000
Q4 2020 Feb 04, 2021	SELL	$18.83 - $63.53 $3,332 - $11,244	-177 Reduced 61.46%	111 $6,000
Q2 2019 Jul 24, 2019	BUY	$13.88 - $18.41 $749 - $994	54 Added 23.08%	288 $5,000
Q1 2018 May 02, 2018	BUY	$19.43 - $34.95 $4,546 - $8,178	234 New	234 $5,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Intellia Therapeutics, Inc. Transaction History